Growth hormone secretagogue receptor‐1a mediates ghrelin's effects on attenuating tumour‐induced loss of muscle strength but not muscle mass
Abstract Background Ghrelin may ameliorate cancer cachexia (CC) by preventing anorexia, muscle, and fat loss. However, the mechanisms mediating these effects are not fully understood. This study characterizes the pathways involved in muscle mass and strength loss in the Lewis lung carcinoma (LLC)‐in...
Main Authors: | Haiming Liu, Pu Zang, Ian (In‐gi) Lee, Barbara Anderson, Anthony Christiani, Lena Strait‐Bodey, Beatrice A. Breckheimer, Mackenzie Storie, Alison Tewnion, Kora Krumm, Theresa Li, Brynn Irwin, Jose M. Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.12743 |
Similar Items
-
EXT418, a novel long‐acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice
by: Haiming L. Kerr, et al.
Published: (2023-06-01) -
Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery
by: Cecilia T. de Barros, et al.
Published: (2020-08-01) -
Mutational analysis of ghrelin and the growth hormone secretagogue receptor
by: Gueorguiev, M, et al.
Published: (2004) -
Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science
by: Alessia Lena, et al.
Published: (2020-09-01) -
MicroRNAs in muscle wasting
by: Tsuyoshi Suzuki, et al.
Published: (2018-12-01)